Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis

Tian Tian,Zhan-Hong Chen,Zongheng Zheng,Yubo Liu,Qi Zhao,Yuying Liu,Huijun Qiu,Qian Long,Miao Chen,Liren Li,Fangyun Xie,Guangyu Luo,Xiaojun Wu,Wuguo Deng
DOI: https://doi.org/10.7150/thno.43427
IF: 11.6
2020-01-01
Theranostics
Abstract:<p><b>Background:</b> Metastatic colorectal cancer (CRC) is a lethal disease; however, the underlying molecular mechanisms remain unclear and require further study.</p><p><b>Methods:</b> RNA-Seq, PCR, Western blotting, immunohistochemistry, ChIP and RNAi assays were performed to investigate Rho GTPase-activating protein 5 (ARHGAP5, aslo known as p190RhoGAP-B, p190-B) expression and the clinical relevance, functional roles and regulatory mechanisms of this protein using human CRC cells and tissues. <i>In vivo</i>, two cell-based xenograft models were used to evaluate the roles of ARHGAP5 in CRC metastasis.</p><p><b>Results:</b> Here, we report that ARHGAP5 expression is significantly increased in metastatic CRC tissues and is inversely associated with patient overall survival. The suppression of ARHGAP5 reduces CRC cell metastasis <i>in vitro</i> and in cell-based xenograft models. Furthermore, we show that ARHGAP5 promotes CRC cell epithelial-mesenchymal transition by negatively regulating RhoA activity. Mechanistically, cAMP response element-binding protein (CREB1) transcriptionally upregulates ARHGAP5 expression, and decreased miR-137 further contributes to ARHGAP5 mRNA stability in CRC.</p><p><b>Conclusions:</b> Overall, our study highlights the crucial function of ARHGAP5 in CRC metastasis, thus suggesting novel prognostic biomarkers and hypothetical therapeutic targets.</p>
medicine, research & experimental
What problem does this paper attempt to address?